Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 15 | 2025 | 296 | 5.140 |
Why?
|
| Kidney | 15 | 2025 | 286 | 3.160 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 6 | 2025 | 37 | 2.540 |
Why?
|
| Polycystic Kidney Diseases | 6 | 2024 | 26 | 1.960 |
Why?
|
| Monocytes | 4 | 2023 | 135 | 1.500 |
Why?
|
| Cilia | 4 | 2022 | 41 | 1.360 |
Why?
|
| Mice | 26 | 2025 | 4655 | 1.300 |
Why?
|
| Kidney Diseases, Cystic | 3 | 2024 | 10 | 1.260 |
Why?
|
| Cysts | 4 | 2023 | 22 | 1.260 |
Why?
|
| Liver Cirrhosis | 2 | 2021 | 72 | 1.240 |
Why?
|
| Animals | 32 | 2025 | 10416 | 1.210 |
Why?
|
| Immunity, Innate | 2 | 2020 | 225 | 1.090 |
Why?
|
| Thymocytes | 1 | 2024 | 13 | 0.910 |
Why?
|
| Immunologic Surveillance | 1 | 2024 | 2 | 0.870 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 1573 | 0.810 |
Why?
|
| Liver | 4 | 2023 | 441 | 0.780 |
Why?
|
| Kidney Diseases | 1 | 2023 | 60 | 0.780 |
Why?
|
| Cell Differentiation | 2 | 2024 | 407 | 0.770 |
Why?
|
| Liver Diseases | 1 | 2023 | 52 | 0.770 |
Why?
|
| Pathology, Veterinary | 1 | 2020 | 1 | 0.700 |
Why?
|
| Veterinarians | 1 | 2020 | 1 | 0.700 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 38 | 0.660 |
Why?
|
| Chemokines | 1 | 2020 | 74 | 0.650 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2019 | 12 | 0.620 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2019 | 58 | 0.620 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 58 | 0.610 |
Why?
|
| Mice, Knockout | 7 | 2024 | 847 | 0.600 |
Why?
|
| Antigens, Ly | 1 | 2018 | 9 | 0.580 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 96 | 0.580 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 105 | 0.570 |
Why?
|
| Epithelium | 1 | 2018 | 40 | 0.570 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 1462 | 0.560 |
Why?
|
| Transforming Growth Factor beta | 2 | 2016 | 79 | 0.510 |
Why?
|
| Calbindin 2 | 1 | 2016 | 3 | 0.510 |
Why?
|
| Neointima | 1 | 2016 | 4 | 0.500 |
Why?
|
| Collagen Type I | 1 | 2016 | 27 | 0.500 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 12 | 0.500 |
Why?
|
| Fibrosis | 4 | 2025 | 134 | 0.490 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 38 | 0.490 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 77 | 0.480 |
Why?
|
| Signal Transduction | 3 | 2016 | 1433 | 0.440 |
Why?
|
| NFATC Transcription Factors | 1 | 2013 | 14 | 0.410 |
Why?
|
| Calreticulin | 1 | 2013 | 5 | 0.410 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 80 | 0.400 |
Why?
|
| Flow Cytometry | 4 | 2024 | 288 | 0.380 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 116 | 0.380 |
Why?
|
| Male | 11 | 2025 | 13511 | 0.370 |
Why?
|
| Phenotype | 3 | 2023 | 679 | 0.340 |
Why?
|
| Rats | 3 | 2021 | 1568 | 0.340 |
Why?
|
| Parabiosis | 2 | 2021 | 17 | 0.330 |
Why?
|
| Spleen | 4 | 2021 | 112 | 0.290 |
Why?
|
| Biomarkers | 3 | 2023 | 763 | 0.290 |
Why?
|
| Female | 9 | 2024 | 15192 | 0.280 |
Why?
|
| Humans | 14 | 2025 | 28168 | 0.270 |
Why?
|
| Inflammation | 4 | 2021 | 633 | 0.270 |
Why?
|
| Mutation | 2 | 2022 | 849 | 0.260 |
Why?
|
| Up-Regulation | 2 | 2018 | 245 | 0.250 |
Why?
|
| Cells, Cultured | 3 | 2019 | 985 | 0.250 |
Why?
|
| Organoids | 1 | 2025 | 22 | 0.240 |
Why?
|
| Cell Line | 3 | 2020 | 694 | 0.240 |
Why?
|
| T-Lymphocytes | 3 | 2024 | 283 | 0.240 |
Why?
|
| Receptors, Immunologic | 2 | 2024 | 72 | 0.230 |
Why?
|
| Osteopontin | 1 | 2024 | 10 | 0.230 |
Why?
|
| Neurogenesis | 1 | 2024 | 22 | 0.230 |
Why?
|
| Ventricular Function, Left | 1 | 2025 | 112 | 0.230 |
Why?
|
| Stroke Volume | 1 | 2025 | 123 | 0.230 |
Why?
|
| Folic Acid | 1 | 2024 | 32 | 0.230 |
Why?
|
| Stem Cells | 1 | 2025 | 122 | 0.220 |
Why?
|
| Thymus Gland | 1 | 2024 | 54 | 0.220 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2024 | 50 | 0.220 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2025 | 75 | 0.220 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 21 | 0.220 |
Why?
|
| Myocardium | 1 | 2025 | 192 | 0.220 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2023 | 7 | 0.210 |
Why?
|
| Membrane Glycoproteins | 2 | 2024 | 145 | 0.210 |
Why?
|
| Receptors, Chemokine | 1 | 2023 | 11 | 0.210 |
Why?
|
| Cell Proliferation | 3 | 2024 | 806 | 0.210 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 137 | 0.200 |
Why?
|
| Transcriptome | 1 | 2024 | 214 | 0.200 |
Why?
|
| Homeostasis | 1 | 2024 | 117 | 0.200 |
Why?
|
| Heart Failure | 1 | 2025 | 247 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2024 | 253 | 0.190 |
Why?
|
| Rats, Inbred Lew | 1 | 2021 | 34 | 0.180 |
Why?
|
| Informatics | 1 | 2020 | 3 | 0.170 |
Why?
|
| Pathologists | 1 | 2020 | 8 | 0.170 |
Why?
|
| Cytokines | 2 | 2021 | 446 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 276 | 0.170 |
Why?
|
| Polychlorinated Dibenzodioxins | 2 | 2011 | 12 | 0.170 |
Why?
|
| Mevalonic Acid | 1 | 2019 | 2 | 0.160 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 6 | 0.160 |
Why?
|
| Interferon Regulatory Factors | 1 | 2020 | 58 | 0.160 |
Why?
|
| Brain | 1 | 2024 | 739 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 58 | 0.150 |
Why?
|
| Species Specificity | 1 | 2019 | 192 | 0.150 |
Why?
|
| Models, Animal | 1 | 2019 | 128 | 0.150 |
Why?
|
| Obesity | 1 | 2024 | 668 | 0.150 |
Why?
|
| Analysis of Variance | 1 | 2019 | 390 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 544 | 0.140 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2024 | 110 | 0.130 |
Why?
|
| Viral Vaccines | 1 | 2016 | 13 | 0.130 |
Why?
|
| Antigens, Viral | 1 | 2016 | 24 | 0.130 |
Why?
|
| Adenoviridae | 1 | 2016 | 67 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 133 | 0.130 |
Why?
|
| Ligation | 1 | 2016 | 40 | 0.130 |
Why?
|
| Disease Progression | 1 | 2018 | 474 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 633 | 0.120 |
Why?
|
| Adult | 4 | 2023 | 7765 | 0.120 |
Why?
|
| Carotid Arteries | 1 | 2016 | 54 | 0.120 |
Why?
|
| Sensation | 1 | 2015 | 13 | 0.120 |
Why?
|
| Embryonic Development | 1 | 2015 | 21 | 0.120 |
Why?
|
| Transfection | 1 | 2016 | 318 | 0.120 |
Why?
|
| United States | 1 | 2020 | 2151 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 2021 | 0.110 |
Why?
|
| CD36 Antigens | 1 | 2013 | 8 | 0.100 |
Why?
|
| Bleomycin | 1 | 2013 | 11 | 0.100 |
Why?
|
| Lung Injury | 1 | 2013 | 32 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 78 | 0.100 |
Why?
|
| Aged | 2 | 2019 | 5417 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2013 | 155 | 0.100 |
Why?
|
| Calcium | 1 | 2013 | 235 | 0.090 |
Why?
|
| Collagen | 1 | 2013 | 156 | 0.090 |
Why?
|
| Time Factors | 1 | 2016 | 1593 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 402 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 187 | 0.090 |
Why?
|
| Middle Aged | 2 | 2019 | 7164 | 0.090 |
Why?
|
| Malathion | 1 | 2010 | 1 | 0.080 |
Why?
|
| Piperonyl Butoxide | 1 | 2010 | 1 | 0.080 |
Why?
|
| Lung | 1 | 2013 | 376 | 0.080 |
Why?
|
| Pesticides | 1 | 2010 | 10 | 0.080 |
Why?
|
| Autoimmunity | 1 | 2011 | 156 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2009 | 164 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 284 | 0.070 |
Why?
|
| Nephrons | 1 | 2025 | 9 | 0.060 |
Why?
|
| Receptors, CCR2 | 1 | 2025 | 15 | 0.060 |
Why?
|
| Pregnancy | 2 | 2024 | 1191 | 0.060 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2024 | 64 | 0.050 |
Why?
|
| B7-1 Antigen | 1 | 2023 | 11 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 991 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 38 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2025 | 301 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2024 | 247 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2023 | 302 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 451 | 0.050 |
Why?
|
| Organ Size | 2 | 2011 | 86 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 463 | 0.040 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2019 | 18 | 0.040 |
Why?
|
| Acetyl Coenzyme A | 1 | 2019 | 18 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2019 | 24 | 0.040 |
Why?
|
| Body Weight | 2 | 2011 | 252 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 363 | 0.040 |
Why?
|
| Turkeys | 1 | 2016 | 3 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 2016 | 7 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 116 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 521 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 43 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 112 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 71 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 3128 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 113 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 17 | 0.020 |
Why?
|
| Cardiolipins | 1 | 2011 | 12 | 0.020 |
Why?
|
| Complement C3 | 1 | 2011 | 21 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 58 | 0.020 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2011 | 12 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 180 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2010 | 60 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2011 | 183 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 242 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 774 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 270 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 373 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 258 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 1987 | 6 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1987 | 19 | 0.020 |
Why?
|
| Genes | 1 | 1987 | 36 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1987 | 137 | 0.000 |
Why?
|
| Base Sequence | 1 | 1987 | 585 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1987 | 690 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1987 | 1052 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1987 | 658 | 0.000 |
Why?
|